Your browser doesn't support javascript.
loading
Lymphopenia assessed during routine follow-up after immunochemotherapy (R-CHOP) is a risk factor for predicting relapse in patients with diffuse large B-cell lymphoma.
Porrata, L F; Rsitow, K; Inwards, D J; Ansell, S M; Micallef, I N; Johnston, P B; Habermann, T M; Witzig, T E; Colgan, J P; Nowakowski, G S; Thompson, C A; Markovic, S N.
Affiliation
  • Porrata LF; Division of Hematology, Department of Medicine, Mayo Clinic College of Medicine, Rochester, MN 55905, USA.
Leukemia ; 24(7): 1343-9, 2010 Jul.
Article in En | MEDLINE | ID: mdl-20485372
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Lymphoma, Large B-Cell, Diffuse / Lymphopenia / Neoplasm Recurrence, Local Type of study: Etiology_studies / Observational_studies / Prognostic_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2010 Document type: Article Affiliation country: Estados Unidos Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Lymphoma, Large B-Cell, Diffuse / Lymphopenia / Neoplasm Recurrence, Local Type of study: Etiology_studies / Observational_studies / Prognostic_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2010 Document type: Article Affiliation country: Estados Unidos Country of publication: Reino Unido